Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3)

BackgroundMachado-Joseph disease (MJD), also named spinocerebellar ataxia type 3 (SCA3) is the most common autosomal dominant ataxia worldwide. Although nystagmus is one of the most frequently reported ocular alterations in MJD patients its behaviour during the course of the disease, namely in its early stages, has only recently started to be investigated. The main goal of this work was to characterize the frequency of nystagmus in symptomatic and presymptomatic carriers of the MJD mutation, and investigate its usefulness as an early indicator of the disease.MethodsWe conducted an observational study of Azorean MJD family members, comprising a total of 158 subjects which underwent neurological evaluation. Sixty eight were clinically and molecularly diagnosed with MJD, 48 were confirmed asymptomatic carriers and 42 were confirmed non-carriers of the MJD mutation. The frequency of nystagmus was calculated for the 3 groups.ResultsNystagmus was present in 88% of the MJD patients. Seventeen percent of the at-risk subjects with a carrier result in the molecular test and none of the 42 individuals who received a non-carrier test result displayed nystagmus (p < 0.006). Although not reaching statistical significance, symptomatic subjects showing nystagmus had a tendency for a higher length of the CAG tract in the expanded allele, when compared to individuals who did not have nystagmus.ConclusionsThe frequency of nystagmus in asymptomatic carriers and its absence in non-carriers of the mutation, suggests that nystagmus may appear before gait disturbance and can thus be considered an early sign of MJD.

[1]  K Fukushima,et al.  Dissociation of smooth pursuit and vestibulo-ocular reflex cancellation in SCA-6 , 2000, Neurology.

[2]  J. Bogousslavsky,et al.  Eye movement abnormalities. , 2012 .

[3]  M. Hallett,et al.  International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome , 1997, Journal of the Neurological Sciences.

[4]  G. Rouleau,et al.  Improvement in the molecular diagnosis of Machado-Joseph disease. , 2001, Archives of neurology.

[5]  Y. Kagawa,et al.  The gene for Machado–Joseph disease maps to human chromosome 14q , 1993, Nature Genetics.

[6]  N. Shimizu.  [Neurology of eye movements]. , 2000, Rinsho shinkeigaku = Clinical neurology.

[7]  P. Coutinho,et al.  Clinical criteria for diagnosis of Machado‐Joseph disease , 1980, Neurology.

[8]  C. Kieling,et al.  A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3) , 2008, European journal of neurology.

[9]  A Dürr,et al.  Eye movement abnormalities correlate with genotype in autosomal dominant cerebellar ataxia type I , 1998, Annals of neurology.

[10]  Alexandra Durr,et al.  Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data , 2013, The Lancet Neurology.

[11]  C. Andrade,et al.  Autosomal dominant system degeneration in Portuguese families of the Azores Islands , 1978, Neurology.

[12]  Nancy J. Newman,et al.  The Neurology of Eye Movements, 4th Edition , 2007 .

[13]  Peka Christova,et al.  Impaired eye movements in presymptomatic spinocerebellar ataxia type 6. , 2008, Archives of neurology.

[14]  Jane S. Paulsen,et al.  Preparing for preventive clinical trials: the Predict-HD study. , 2006, Archives of neurology.

[15]  P. Bugalho,et al.  Autosomal dominant cerebellar ataxia: frequency analysis and clinical characterization of 45 families from Portugal , 2010, European journal of neurology.

[16]  Wolfgang Heide,et al.  Slow saccades and other eye movement disorders in spinocerebellar atrophy type 1 , 1997, Journal of Neurology.

[17]  R. Leigh,et al.  THE NEUROLOGY OF EYE MOVEMENTS FOURTH EDITION , 2006 .

[18]  R. Giugliani,et al.  Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n. , 2001, Archives of neurology.

[19]  D. Timmann,et al.  Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6 , 2008, Movement disorders : official journal of the Movement Disorder Society.

[20]  J. Dichgans,et al.  Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3 , 1999, Journal of Neurology.

[21]  M. Lima,et al.  Machado-Joseph Disease: from first descriptions to new perspectives , 2011, Orphanet journal of rare diseases.

[22]  Maria Coutinho.  Doença de Machado-Joseph : Tentativa de definição , 1992 .

[23]  P. Coutinho,et al.  Epidemiology and clinical aspects of Machado-Joseph disease. , 1993, Advances in neurology.

[24]  R. Baloh,et al.  Slowing of voluntary and involuntary saccades: An early sign in spinocerebellar ataxia type 7 , 2001, Annals of neurology.

[25]  Shigenobu Nakamura,et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.

[26]  Michael Fetter,et al.  Saccade Velocity as a Surrogate Disease Marker in Spinocerebellar Ataxia Type 2 , 2005, Annals of the New York Academy of Sciences.